Novel Genomic Technology Development Direct to Phase II SBIR (R44)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

This Funding Opportunity Announcement (FOA) encourages Direct to Phase II SBIR grant applications from small businesses to catalyze major advances in genomics through technology development (beyond developing nucleic acid sequencing technologies). The goal is to provide a mechanism for support of very novel and high impact work from across this gamut of genomics technology development. This initiative seeks to support technologies that will have a major impact in the next three to five years.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedOct 27, 2015
  • ClosesJan 11, 2017
  • CFDA93.172
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro